Internationally recognized for his achievements in the medical technology industry, Fuad El-Hibri is the founder and executive chairman of Emergent BioSolutions of Rockville, Maryland. The former CEO of Emergent, Fuad El-Hibri was responsible for the oversight and development of various pharmaceuticals and was named Biotech CEO of the Year at the World Vaccine Congress in 2011.
The largest vaccine conference on the planet, the World Vaccine Congress takes place annually in Washington, DC, and recognizes innovation in the pharmaceutical industry. More than 60 percent of conference attendees come from biotech, pharmaceuticals, and government bodies, and represent North America, Europe, Asia, the Middle East, and Africa.
Various award categories are represented each year, and they can include anything from best clinical trial site to best early-stage biotech company. Each award has its own unique set of criteria for which ViE panels judge. To be recognized as the Biotech CEO of the year, candidates’ abilities to grow business from an early stage to mature company is taken into consideration. Judges also look at licensing and partnerships deals, acquisition of new funds, and other factors.